Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Operating Leases (2023 - 2025)

Abpro Holdings' (ABPO) quarterly Operating Leases came in at $456000.0 in Q4 2025, down 19.43% YoY from $566000.0 in Q4 2024, and down 19.43% on a QoQ basis from $566000.0 in Q4 2024.

Abpro Holdings (ABPO) Operating Leases (2023 - 2025) Analysis & Trends

Abpro Holdings (ABPO) has 3 years of Operating Leases data on file, last reported at $456000.0 in Q4 2025.

  • Quarterly Operating Leases fell 19.43% year-over-year to $456000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $456000.0 (down 19.43% YoY) and the FY2025 annual result came in at $456000.0, down 19.43% from the prior year.
  • Operating Leases declined to $456000.0 in Q4 2025, from $566000.0 in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $566000.0 in Q4 2024 to a low of $455000.0 in Q4 2023.
  • A 3-year average of $492333.3 and a median of $456000.0 in 2025 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2024 — Operating Leases climbed 24.4% — and 2025, when it fell 19.43%.
  • Tracing ABPO's Operating Leases over 3 years: stood at $455000.0 in 2023, then increased by 24.4% to $566000.0 in 2024, then retreated by 19.43% to $456000.0 in 2025.
  • The last three Operating Leases figures came in at $456000.0 (Q4 2025), $566000.0 (Q4 2024), and $455000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Abpro Holdings 1.14 Mn 1.14 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 456,000.00
Dec 31, 2024 566,000.00
Dec 31, 2023 455,000.00